» Articles » PMID: 20052456

Noninvasive and Invasive Ventilation in Acute Respiratory Failure Associated with Bronchiectasis

Overview
Specialty Critical Care
Date 2010 Jan 7
PMID 20052456
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To describe the outcomes of patients with bronchiectasis and acute respiratory failure (ARF) treated with noninvasive ventilation (NIV) and invasive mechanical ventilation (IMV) after a failure of conservative measures, and to identify the predictors of hospital mortality and NIV failure.

Methods: Retrospective review of bronchiectatic patients on NIV (n = 31) or IMV (n = 26) for ARF over 8 years in a medical intensive care unit (ICU) experienced in NIV.

Results: At baseline, the NIV group had more patients with acute exacerbations without identified precipitating factors (87.1 vs. 34.6%, p < 0.001), higher pH (mean 7.25 vs. 7.18, p = 0.008) and PaO(2)/FiO(2) ratio (mean 249.4 vs. 173.2, p = 0.02), and a trend towards a lower APACHE II score (mean 25.3 vs. 28.4, p = 0.07) than the IMV group. There was no difference in hospital mortality between the two groups (25.8 vs. 26.9%, p > 0.05). The NIV failure rate (need for intubation or death in the ICU) was 32.3%. Using logistic regression, the APACHE II score was the only predictor of hospital mortality (OR 1.19 per point), and the PaO(2)/FiO(2) ratio was the only predictor of NIV failure (OR 1.02 per mmHg decrease).

Conclusions: The hospital mortality of patients with bronchiectasis and ARF approximates 25% and is predicted by the APACHE II score. When selectively applied, NIV fails in one-third of the patients, and this is predicted by hypoxemia. Our findings call for randomised controlled trials to compare NIV versus IMV in such patients.

Citing Articles

Effects of high-flow nasal cannula oxygen therapy in bronchiectasis and hypercapnia: a retrospective observational study.

Yang J, Chen L, Yu H, Hu J, Qiu F BMC Pulm Med. 2024; 24(1):217.

PMID: 38698379 PMC: 11067275. DOI: 10.1186/s12890-024-03037-2.


Epidemiology and outcomes of multidrug-resistant bacterial infection in non-cystic fibrosis bronchiectasis.

Chang C, Chang C, Huang S, Lee C, Ko P, Lin C Ann Clin Microbiol Antimicrob. 2024; 23(1):15.

PMID: 38350983 PMC: 10865664. DOI: 10.1186/s12941-024-00675-6.


Risk Factors for Influenza-Induced Exacerbations and Mortality in Non-Cystic Fibrosis Bronchiectasis.

Huang H, Lo C, Chung F, Huang Y, Ko P, Lin C Viruses. 2023; 15(2).

PMID: 36851751 PMC: 9961441. DOI: 10.3390/v15020537.


Influence of Comorbidities and Airway Clearance on Mortality and Outcomes of Patients With Severe Bronchiectasis Exacerbations in Taiwan.

Huang H, Chung F, Lin C, Lo C, Huang Y, Huang Y Front Med (Lausanne). 2022; 8:812775.

PMID: 35127767 PMC: 8814605. DOI: 10.3389/fmed.2021.812775.


A challenging case of hypercapnic respiratory failure during pregnancy.

Vijayakumar B, Cao M, Mackillop L, Sarangmat N, Leite M, Wathen C Obstet Med. 2021; 14(2):121-124.

PMID: 34394724 PMC: 8358241. DOI: 10.1177/1753495X20944707.


References
1.
Jolliet P, Abajo B, Pasquina P, Chevrolet J . Non-invasive pressure support ventilation in severe community-acquired pneumonia. Intensive Care Med. 2001; 27(5):812-21. PMC: 7095297. DOI: 10.1007/s001340100869. View

2.
Boles J, Bion J, Connors A, Herridge M, Marsh B, Melot C . Weaning from mechanical ventilation. Eur Respir J. 2007; 29(5):1033-56. DOI: 10.1183/09031936.00010206. View

3.
Barker A, Bardana Jr E . Bronchiectasis: update of an orphan disease. Am Rev Respir Dis. 1988; 137(4):969-78. DOI: 10.1164/ajrccm/137.4.969. View

4.
Fernandez R, Baigorri F, Artigas A . Noninvasive ventilation in patients with "do-not-intubate" orders: medium-term efficacy depends critically on patient selection. Intensive Care Med. 2006; 33(2):350-4. DOI: 10.1007/s00134-006-0437-6. View

5.
Ai-Ping C, Lee K, Lim T . In-hospital and 5-year mortality of patients treated in the ICU for acute exacerbation of COPD: a retrospective study. Chest. 2005; 128(2):518-24. DOI: 10.1378/chest.128.2.518. View